Crohn's Disease Clinical Trials in New York

Showing 41-60 of 102 trials

Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

NCT03998488

A double-blind, randomized, placebo-controlled clinical trial examining the efficacy and safety of Fecal Microbiota Transplantation (FMT) and high fiber supplementation in patients with active mild to moderate Ulcerative Colitis (UC). All enrolled subjects will provide serological, stool and mucosal specimen at each clinic visit to help further define the alterations in microbial profiles and immune cell function in response to psyllium fiber after FMT treatment.

Ulcerative ColitisInflammatory Bowel Diseases

Weill Medical College of Cornell University27 participantsStarted Jan 2020

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385

This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.

Crohn Disease

Celgene606 participantsStarted Mar 2018

Scottsdale, Arizona, United States • La Jolla, California, United States • Lancaster, California, United States +365 more locations

Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Crohn's Disease Trials in Other Cities

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Induction Optimization With Stelara for Crohn's Disease

Entyvio (Vedolizumab) Long Term Safety Study

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)

B0151005 Open-Label Extension Study

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Transcutaneous VNS to Treat Pediatric IBD

Fecal Microbial Transplantation in Patients With Crohn's Disease

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease

Other Conditions in New York